Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 4 of 4

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract May 2006

Demographics and Baseline Characteristics of Patients in the Anecortave Acetate Risk Reduction Trial (AART)

J.S. Slakter; Anecortave Acetate Clinical Study Group

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):2109.

ARVO Annual Meeting Abstract May 2005

Safety Outcomes of Clinical Studies for Anecortave Acetate in Patients With Exudative Age–Related Macular Degeneration (AMD)

C.D. Regillo; D. D'Amico; W. Mieler; C. Beasley; Anecortave Acetate Clinical Study Group

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):1373.

ARVO Annual Meeting Abstract May 2005

Baseline Characteristics of a Phase 3 Clinical Study of Anecortave Acetate 15 mg in Patients With Exudative Age–Related Macular Degeneration (AMD)

J.S. Slakter; J. Jerdan; F.E. Kane; P. Zilliox; D. Turner; S.M. Robertson; A. Ciardella; Anecortave Acetate Clinical Study Group

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):1374.

ARVO Annual Meeting Abstract May 2005

Reflux of Study Medication Affects the Clinical Outcomes of Anecortave Acetate for Depot Suspension in the Treatment of Patients With Exudative Age–Related Macular Degeneration (AMD)

T.W. Bochow; C.A. Harper, III; B.B. Marks; E. Trost; E.K. Sullivan; Anecortave Acetate Clinical Study Group

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):2366.

Advertisement